Can counseling and support reduce burden and depressive symptoms in caregivers of people with Alzheimer's disease during the transition to institutionalization? Results from the New York University caregiver intervention study

Journal of the American Geriatrics Society
Joseph E GauglerMary Mittelman

Abstract

To determine whether counseling and support reduce the burden and depressive symptoms of spouse caregivers of patients with Alzheimer's disease (AD) during the transition to institutionalization. A randomized, controlled trial of an enhanced counseling and support program for spouse caregivers of persons with AD. Structured interviews were conducted with spouse caregivers at baseline, every 4 months during Year 1, and every 6 months thereafter for up to 16 years. Outpatient research clinic in the New York City metropolitan area. Referred volunteer sample of 406 spouse caregivers of community-dwelling patients with AD enrolled over a 9.5-year period. Enhanced counseling and support consisting of six sessions of individual and family counseling, support group participation, and continuous availability of ad hoc telephone counseling. Outcome measures included burden (modified Zarit Burden Interview) and depressive symptoms (Geriatric Depression Scale). Burden and depressive symptoms were significantly lower for caregivers in the treatment group than for controls receiving usual care at the time of and after institutionalization. Nursing home admission itself significantly reduced burden and depressive symptoms in the intervention ...Continue Reading

References

Dec 1, 1980·The Gerontologist·S H ZaritJ Bach-Peterson
Dec 22, 1999·JAMA : the Journal of the American Medical Association·R Schulz, S R Beach
Aug 8, 2001·The Gerontologist·C J WhitlatchW J Looman
Sep 28, 2001·The Gerontologist·C L PortJ Magaziner
Jun 1, 2002·The Gerontologist·Silvia SörensenPaul Duberstein
Jul 30, 2002·The Gerontologist·Jane B Tornatore, Leslie A Grant
Sep 28, 2002·The Gerontologist·Richard SchulzAlan Stevens
Mar 21, 2003·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Martin Pinquart, Silvia Sörensen
Nov 6, 2003·Psychological Bulletin·Peter P VitalianoJames M Scanlan
May 4, 2004·The American Journal of Psychiatry·Mary S MittelmanWilliam E Haley
Aug 26, 2004·JAMA : the Journal of the American Medical Association·Richard SchulzSong Zhang
Nov 23, 2006·Annals of Internal Medicine·Steven H BelleUNKNOWN Resources for Enhancing Alzheimer's Caregiver Health (REACH) II Investigators
Jun 2, 2007·The American Journal of Psychiatry·Robert S WilsonDenis A Evans
Jun 21, 2007·BMC Geriatrics·Joseph E GauglerRobert L Kane

❮ Previous
Next ❯

Citations

Feb 1, 2011·Irish Journal of Medical Science·C O'Connor
Feb 22, 2013·International Psychogeriatrics·Laura SuryHenry Brodaty
Sep 21, 2010·Social Work in Health Care·Katherina A Nikzad-TerhuneJoseph E Gaugler
Aug 14, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jerri D EdwardsDavid L Roth
Jan 23, 2013·The Gerontologist·Joseph E GauglerMary S Mittelman
Jan 31, 2012·Dementia and Geriatric Cognitive Disorders·Ton J E M BakkerMiel W Ribbe
May 22, 2013·BMC Public Health·Yueh-Mei GauLee Stewart
May 22, 2013·Progress in Neurobiology·Marjolein E de Vugt, Frans R J Verhey
Jul 31, 2010·Journal of Gerontological Nursing·Cherie ParkerAnita Macan
Nov 17, 2011·Journal of Gerontological Nursing·Olimpia Paun, Carol J Farran
May 3, 2014·Nursing Forum·Sarah LlanqueMichael Caserta
Oct 13, 2015·Intellectual and Developmental Disabilities·Tamar HellerDora Fisher
Aug 22, 2015·Neurodegenerative Disease Management·Colleen A RayJiska Cohen-Mansfield
Oct 13, 2012·Arquivos de neuro-psiquiatria·Patrícia Paes Araujo FialhoPaulo Caramelli
Jan 23, 2017·Health and Quality of Life Outcomes·Catherine ReedJosep Maria Haro
Feb 19, 2016·American Journal of Alzheimer's Disease and Other Dementias·Sung-In JangEun-Cheol Park
Sep 18, 2010·Journal of Aging and Health·Hsin ChuKuei-Ru Chou
May 31, 2017·Journal of Gerontological Nursing·Annette M LaneAlina Rokhman
Jun 19, 2014·Dementia·Lynsey J Brown, Malcolm J Bond
Jun 25, 2017·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Elizabeth B FauthMary Mittelman
May 29, 2018·Dementia and Geriatric Cognitive Disorders Extra·Angus M J ProsserChristopher M Kipps
Jul 11, 2018·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Hideyuki TerayamaHaruo Hanyu
Jul 12, 2018·International Psychogeriatrics·Brenda VrkljanBarbara Mazer
Sep 16, 2010·International Journal of Geriatric Psychiatry·Jennifer Duncan DavisRichard H Fortinsky
Aug 31, 2010·International Journal of Geriatric Psychiatry·P Connelly
Aug 18, 2018·Irish Journal of Psychological Medicine·I GresswellG M McCarthy
Mar 12, 2013·International Psychogeriatrics·Vasiliki Orgeta, Elena Lo Sterzo
Oct 19, 2017·The Gerontologist·Willow C Glasier, Kelly J Arbeau
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Myrra Vernooij-DassenMurna Downs
May 13, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.